HK1208860A1 - The compound for preparing isofagomine - Google Patents

The compound for preparing isofagomine

Info

Publication number
HK1208860A1
HK1208860A1 HK15109393.7A HK15109393A HK1208860A1 HK 1208860 A1 HK1208860 A1 HK 1208860A1 HK 15109393 A HK15109393 A HK 15109393A HK 1208860 A1 HK1208860 A1 HK 1208860A1
Authority
HK
Hong Kong
Prior art keywords
compound
isofagomine
preparing
preparing isofagomine
Prior art date
Application number
HK15109393.7A
Other languages
English (en)
Chinese (zh)
Inventor
‧馬格瑞斯
‧特列基亞可夫
‧福斯特
‧舍思
‧瑞比克金斯基
‧朱
Original Assignee
Amicus Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicus Therapeutics Inc filed Critical Amicus Therapeutics Inc
Publication of HK1208860A1 publication Critical patent/HK1208860A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
HK15109393.7A 2007-05-22 2010-08-30 The compound for preparing isofagomine HK1208860A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93951907P 2007-05-22 2007-05-22

Publications (1)

Publication Number Publication Date
HK1208860A1 true HK1208860A1 (en) 2016-03-18

Family

ID=40122224

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15109393.7A HK1208860A1 (en) 2007-05-22 2010-08-30 The compound for preparing isofagomine
HK10108227.6A HK1141719A1 (zh) 2007-05-22 2010-08-30 用於製備異法戈明以及它的衍生物的新方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK10108227.6A HK1141719A1 (zh) 2007-05-22 2010-08-30 用於製備異法戈明以及它的衍生物的新方法

Country Status (14)

Country Link
US (3) US8487110B2 (fr)
EP (1) EP2152265B1 (fr)
JP (1) JP5441894B2 (fr)
KR (4) KR101650726B1 (fr)
CN (2) CN101743002B (fr)
AU (1) AU2008254594B2 (fr)
BR (1) BRPI0812381A2 (fr)
CA (1) CA2688850C (fr)
ES (1) ES2490143T3 (fr)
HK (2) HK1208860A1 (fr)
IL (2) IL202260A (fr)
MX (1) MX2009012593A (fr)
SG (1) SG183747A1 (fr)
WO (1) WO2008144773A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2485369T3 (es) 2005-06-08 2014-08-13 Amicus Therapeutics, Inc. Tratamiento de trastornos del SNC asociados con mutaciones en genes que codifican enzimas lisosómicas
DK2040548T3 (da) 2006-06-23 2012-08-13 Amicus Therapeutics Inc Fremgangsmåde til behandling af neurologiske forstyrrelser ved forøgelse af aktiviteten af beta-glucocerebrosidase
PL2638152T3 (pl) * 2010-11-08 2017-02-28 Amicus Therapeutics, Inc. Warianty rekombinowanych białek beta-glukocerebrozydaz ze zwiększoną stabilnością i zwiększoną zachowaną aktywnością katalityczną
JP6061922B2 (ja) * 2011-06-22 2017-01-18 ザ ジェネラル ホスピタル コーポレイション プロテイノパチーの処置方法
WO2016144773A1 (fr) 2015-03-06 2016-09-15 Abbvie Inc. Glycoprotéines arabinosylées
US11643265B1 (en) * 2017-02-06 2023-05-09 Rational Packaging Llc Corrugated offset corner elements
CN112625010B (zh) * 2020-12-31 2023-03-03 中山大学 一种9-羟基菲醌衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863903A (en) 1994-03-09 1999-01-26 Novo Nordisk A/S Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes
US5844102A (en) 1994-07-07 1998-12-01 University Of Maryland Baltimore County Glycohydrolase inhibitors, their preparation and use thereof
FR2751863B1 (fr) 1996-08-01 1999-01-22 Vitalitec International Support de clips hemostatiques
HUP0003362A3 (en) 1997-05-06 2001-04-28 Novo Nordisk As Piperidine derivatives and pharmaceutical compositions containing them
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
JP2001172250A (ja) * 1999-12-14 2001-06-26 Ono Pharmaceut Co Ltd グルコピラノース誘導体
US6455573B1 (en) 2000-01-07 2002-09-24 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
US8389565B2 (en) * 2000-01-07 2013-03-05 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
US6960654B2 (en) * 2002-06-11 2005-11-01 The Board Of Trustees Of The University Of Illinois Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide
CH697574B1 (de) 2003-01-07 2008-12-15 Lanxess Deutschland Gmbh Pyrazolylarylalkine.
WO2005046611A2 (fr) * 2003-11-12 2005-05-26 Amicus Therapeutics Inc. Derives de gluco-imidazole et de polyhydroxycyclohexenyl-amine pour traiter la maladie de gaucher
US20070065922A1 (en) * 2005-09-21 2007-03-22 Metkinen Oy Biocatalytic synthesis of aminodeoxy purine N9-beta-D-nucleosides containing 3-amino-3-deoxy-beta-D-ribofuranose, 3-amino-2,3-dideoxy-beta-D-ribofuranose, and 2-amino-2-deoxy-beta-D-ribofuranose as sugar moieties
DK1860101T3 (da) * 2006-05-24 2011-07-25 Amicus Therapeutics Inc Tartrat salt af isofagomin og fremgangsmåder til anvendelse deraf

Also Published As

Publication number Publication date
IL202260A (en) 2015-09-24
AU2008254594B2 (en) 2013-06-27
KR20100017879A (ko) 2010-02-16
HK1141719A1 (zh) 2010-11-19
KR101597499B1 (ko) 2016-02-24
JP5441894B2 (ja) 2014-03-12
IL240648A0 (en) 2015-09-24
CN104530068B (zh) 2017-05-03
KR101650726B1 (ko) 2016-08-24
US9481700B2 (en) 2016-11-01
CA2688850C (fr) 2015-08-11
IL240648A (en) 2017-09-28
CN101743002B (zh) 2015-11-25
KR20160041059A (ko) 2016-04-15
US20100160638A1 (en) 2010-06-24
AU2008254594A1 (en) 2008-11-27
KR20150048924A (ko) 2015-05-07
ES2490143T3 (es) 2014-09-03
CN101743002A (zh) 2010-06-16
CN104530068A (zh) 2015-04-22
EP2152265A1 (fr) 2010-02-17
SG183747A1 (en) 2012-09-27
US8487110B2 (en) 2013-07-16
CA2688850A1 (fr) 2008-11-27
KR101789000B1 (ko) 2017-10-20
KR20160102320A (ko) 2016-08-29
JP2010528048A (ja) 2010-08-19
IL202260A0 (en) 2010-06-16
MX2009012593A (es) 2010-01-26
EP2152265B1 (fr) 2014-06-04
EP2152265A4 (fr) 2012-02-01
US20140005372A1 (en) 2014-01-02
US20170044102A1 (en) 2017-02-16
WO2008144773A1 (fr) 2008-11-27
BRPI0812381A2 (pt) 2016-08-09

Similar Documents

Publication Publication Date Title
IL205066A0 (en) Oxadiazolidinedione compound
GB0717839D0 (en) The treepee
GB0706072D0 (en) Compound
GB0700076D0 (en) Compound
GB0720220D0 (en) Compound
IL200152A0 (en) Aza-bridged-ring compound
IL201248A (en) Polates are marked f 18 and methods for preparing them
HK1208860A1 (en) The compound for preparing isofagomine
GB0722779D0 (en) Compound
GB0702228D0 (en) The cosy-cushion
GB0707146D0 (en) The bealyboard
GB0711387D0 (en) The fincubator
GB0701309D0 (en) The easi-strutt
GB0724770D0 (en) Compound
GB0719038D0 (en) Compound
GB0714603D0 (en) Compound
GB0706694D0 (en) Compound
GB0706280D0 (en) Compound
GB0710246D0 (en) The hydra-pack
GB0722537D0 (en) The degravitator
GB0704798D0 (en) The dagice
GB0710701D0 (en) The kaleidosphere
GB0703554D0 (en) The allotpot
GB0711847D0 (en) The potashe
GB0713046D0 (en) The duveze

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210524